Sumarni U, Reidel U, Eberle J. Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP. Cells 2021;10:987. [PMID: 33922439 DOI: 10.3390/cells10050987][Reference Citation Analysis]
2
Zhu L, Xie S, Yang C, Hua N, Wu Y, Wang L, Ni W, Tong X, Fei M, Wang S. Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS). Cancer Manag Res 2021;13:5275-86. [PMID: 34239326 DOI: 10.2147/CMAR.S299505][Reference Citation Analysis]
3
Kołkowski K, Trzeciak M, Sokołowska-Wojdyło M. Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas. Int J Mol Sci 2021;22:13388. [PMID: 34948183 DOI: 10.3390/ijms222413388][Reference Citation Analysis]